An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate ...
SAN DIEGO--(BUSINESS WIRE)--Vektor Medical today announced its vMap ® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by ...
SAN DIEGO, February 17, 2026--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP ...
vMap was invented to help physicians improve ablation outcomes for patients suffering from arrhythmias, such as atrial fibrillation and ventricular tachycardia. Use of vMap has also been associated ...
With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...
The knowledge that recovering Covid-19 patients face an increased risk of cardiac arrhythmia(Opens in a new window) complications, is one factor contributing to the ...
Vektor Medical, a medical technology company headquartered in San Diego redefining how arrhythmias are understood and treated, announced it has received the US Food and Drug Administration 510(k) ...
The patient population of those suffering from cardiac arrhythmias, or an irregular heartbeat, continues to expand: atrial fibrillation affects about 1 in 50 Americans under the age of 65 and about 1 ...
Milestone Highlights Rapid Hospital Adoption and Clinical Demand for Arrhythmia Insights that Improve Outcomes and Reduce Procedure Time vMap, developed with AI and designed to localize both focal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results